NCT00802542View on ClinicalTrials.gov

In-practice Evaluation of Atacand 16mg Antihypertensive Effect

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Essential Hypertension
Trial Locations (4)

Unknown

Research site, Daugavpils

Research site, Jelgava

Research site, Liepāja

Research Site, Riga

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY